American Express
AXP
$355.35
-1.72%
American Express is a global financial institution operating in about 130 countries, providing consumers and businesses with charge and credit card payment products, along with a highly profitable merchant payment network. As a premier brand in the credit services industry, it distinguishes itself through its closed-loop network model, premium customer base, and integrated travel and lifestyle services. The current investor narrative centers on the company's ability to sustain high growth through fee hikes (e.g., Platinum annual fee raised to $895), AI-driven personalization, and strong spending trends among affluent cardholders, while managing credit risk and regulatory scrutiny.…
AXP
American Express
$355.35
Related headlines
Investment Opinion: Should I buy AXP Today?
Rating: Buy. American Express offers a rare combination of accelerating revenue growth, expanding margins, and strong free cash flow, supported by a premium brand and pricing power. The consensus analyst rating is Buy with an average target of $374.94, implying 4.6% upside.
Supporting evidence: (1) Revenue growth accelerated to 10.28% YoY in Q1 2026, outpacing the industry average. (2) Net margin of 14.23% is well above the industry average of ~13.5%. (3) Trailing twelve-month free cash flow of $14.32B provides ample capital returns. (4) Forward PE of 17.77x is a 19% discount to the industry forward average of 22.0x, suggesting undervaluation relative to expected earnings growth. (5) ROE of 32.36% is exceptional, indicating efficient capital use.
Risks & Conditions: The biggest risks are a recession hitting consumer spending and credit losses, and multiple compression from the elevated trailing PE of 24.01x. This Buy rating would be downgraded to Hold if revenue growth decelerates below 8% or if net margin falls below 12%. It would be upgraded if the stock pulls back to the $320 level (near analyst low target) while fundamentals remain intact. Overall, AXP appears fairly valued on a forward basis but slightly overvalued on trailing earnings, making it a buy for growth-oriented investors with a 12-month horizon.
Sign up to view all
AXP 12-Month Price Forecast
American Express is well-positioned for continued growth given its accelerating revenue, expanding margins, and strong free cash flow. The forward PE of 17.77x offers a discount to the industry, suggesting the market is not fully pricing in the earnings growth potential. However, the trailing PE of 24.01x is elevated, and macro risks could trigger multiple compression. The base case of steady growth to $374.94 is most likely, but the bull case of $400+ is achievable if the company sustains its momentum. We would upgrade to high confidence if Q2 2026 revenue growth exceeds 12% and margins expand further.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on American Express's 12-month outlook, with a consensus price target around $374.94 and implied upside of +5.5% versus the current price.
Average Target
$374.94
0 analysts
Implied Upside
+5.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$319 - $450
Analyst target range
The stock is covered by 25 analysts, with a consensus recommendation of 'Buy' (mean rating 2.23 on a 1-5 scale where 1 is Strong Buy). The average target price is $374.94, implying 4.6% upside from the current price of $358.44. The distribution leans bullish: recent actions include upgrades from JP Morgan (Overweight from Neutral) and Piper Sandler (Overweight from Neutral), while HSBC and BTIG remain cautious with Hold and Sell ratings, respectively. The target range spans from a low of $319.00 to a high of $450.00. The high target of $450 assumes continued strong spending, successful fee hikes, and potential multiple expansion, representing 25.5% upside. The low target of $319.00 prices in risks such as credit deterioration, regulatory changes, or a recession impacting consumer spending, implying an 11.0% downside. The wide spread of $131 between low and high targets signals elevated uncertainty about the macroeconomic outlook and the sustainability of premium spending trends. The recent upgrades from major banks suggest growing confidence in the company's growth trajectory, but the presence of a Sell rating from BTIG indicates that not all risks are priced in.
Drowning in data?
Find the real signal!
Bulls vs Bears: AXP Investment Factors
American Express presents a compelling growth story with accelerating revenue, expanding margins, and strong free cash flow, supported by a premium brand and pricing power. The bull case is anchored by 10.28% YoY revenue growth, a 31.60% operating margin, and analyst upgrades. However, the trailing PE of 24.01x is near historical highs, and the debt-to-equity of 1.73 adds financial risk. The most critical tension is whether the company can sustain its growth trajectory and margin expansion to justify the current valuation, or if macro headwinds and competitive pressures will lead to multiple compression. Currently, the bull case has stronger evidence given the accelerating fundamentals, but the valuation leaves limited room for error.
Bullish
- Accelerating Revenue Growth: Q1 2026 revenue grew 10.28% YoY to $20.88B, accelerating from 8.0% in Q4 2025 and 5.2% in Q2 2025, driven by strong consumer spending and higher card fees.
- Exceptional Profitability and Margins: Net margin improved to 14.23% in Q1 2026 from 11.70% in Q4 2025, and operating margin surged to 31.60% from 14.69%, reflecting strong operating leverage.
- Strong Free Cash Flow Generation: Trailing twelve-month free cash flow reached $14.32B, with Q1 2026 FCF of $2.66B, providing ample capacity for dividends, buybacks, and investment.
- Premium Brand and Pricing Power: The Platinum annual fee hike to $895 (29% increase) with near-100% retention demonstrates strong brand loyalty and pricing power, boosting fee revenue.
Bearish
- Elevated Valuation vs. History: Trailing PE of 24.01x is near the high end of its 5-year range (11.3x-26.2x), suggesting the stock is priced for optimistic expectations and vulnerable to multiple compression.
- High Debt-to-Equity Ratio: Debt-to-equity of 1.73 is elevated for a financial firm, increasing financial risk if credit conditions tighten or interest expenses rise.
- Macroeconomic Sensitivity: With beta of 1.045, AXP is market-correlated, and a recession could reduce consumer spending and increase credit losses, pressuring earnings.
- Wide Analyst Target Range: The $131 spread between low ($319) and high ($450) targets signals high uncertainty, with the low target implying 11% downside from current levels.
AXP Technical Analysis
The stock is in a recovery phase after a significant correction, with a 1-year price change of +15.38% but still trading 7.5% below its 52-week high of $387.49. The current price of $358.44 sits at 70% of the 52-week range (from low of $288.34 to high of $387.49), indicating it has reclaimed much of the lost ground but has not yet broken into new highs. This positioning suggests a stock that is rebuilding momentum but still faces overhead resistance. Short-term momentum is strongly positive: the 1-month change is +6.88% and the 3-month change is +10.03%, both outpacing the S&P 500's respective gains of 0.6% and 6.29%. This acceleration in recent months contrasts with the 6-month decline of -1.74%, signaling a potential trend reversal from the earlier downtrend. The relative strength index (RSI) is not provided, but the price action shows a clear upward trajectory since the June lows near $300, with higher lows and higher highs. The 52-week low of $288.34 serves as key support, while the 52-week high of $387.49 is the immediate resistance. A breakout above $387.49 would signal a resumption of the long-term uptrend, while a breakdown below $288.34 would indicate renewed weakness. The stock's beta of 1.045 implies it is roughly as volatile as the market, meaning it should not require outsized risk adjustments relative to the S&P 500.
Beta
1.04
1.04x market volatility
Max Drawdown
-24.1%
Largest decline past year
52-Week Range
$288-$387
Price range past year
Annual Return
+12.7%
Cumulative gain past year
| Period | AXP Return | S&P 500 |
|---|---|---|
| 1m | +4.3% | +0.3% |
| 3m | +7.1% | +4.7% |
| 6m | -2.6% | +7.5% |
| 1y | +12.7% | +18.4% |
| ytd | -4.7% | +9.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AXP Fundamental Analysis
Revenue growth is solid and accelerating: Q1 2026 revenue of $20.88 billion grew 10.28% year-over-year, up from 8.0% in Q4 2025 and 5.2% in Q2 2025. The Global Consumer Services Group segment contributed $9.12 billion, or 43.7% of total revenue, while Global Commercial Services added $4.32 billion. This broad-based growth, driven by strong consumer spending and higher card fees, supports the investment case for continued expansion. Profitability is robust, with net income of $2.97 billion in Q1 2026 and a net margin of 14.23%, up from 11.70% in Q4 2025. Gross margin remains high at 84.56%, reflecting the company's premium positioning and fee-based revenue model. Operating margin improved to 31.60% in Q1 2026 from 14.69% in Q4 2025, driven by operating leverage and cost control. The balance sheet is solid: free cash flow was $2.66 billion in Q1 2026, and trailing twelve-month free cash flow reached $14.32 billion. The debt-to-equity ratio of 1.73 is manageable for a financial firm, and the current ratio of 0.28 is typical for credit card companies given their short-term liability structure. ROE of 32.36% is exceptional, indicating efficient capital use and strong shareholder value creation.
Quarterly Revenue
$20.9B
2026-03
Revenue YoY Growth
+10.3%
YoY Comparison
Gross Margin
84.6%
Latest Quarter
Free Cash Flow
$14.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AXP Overvalued?
Since net income is positive, the PE ratio is the primary valuation metric. The trailing PE is 24.01x, while the forward PE is 17.77x, implying the market expects significant earnings growth in the next 12 months. The gap between trailing and forward PE suggests analysts anticipate EPS expansion from $14.93 (trailing) to $20.17 (forward), a 35% increase. Compared to the industry average PE of 22.0x (estimated), AXP's trailing PE of 24.01x represents a 9% premium. However, the forward PE of 17.77x is a 19% discount to the industry forward average of 22.0x, indicating that the market is pricing in above-average growth. This premium is justified by AXP's superior net margin of 13.46% versus industry averages and its strong brand moat. Historically, AXP's trailing PE has ranged from 11.3x (Q3 2023) to 26.2x (Q4 2025). The current 24.01x is near the higher end of this band, suggesting the stock is priced for optimistic expectations. However, the forward PE of 17.77x is closer to the historical median, implying that if earnings materialize as expected, the valuation is reasonable.
PE
24.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 11x~20x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: AXP's debt-to-equity ratio of 1.73 is high for a financial institution, indicating significant leverage. Interest expense was $1.97B in Q1 2026, up from $1.97B in Q4 2025, and could rise if rates stay elevated. The current ratio of 0.28 is typical for credit card companies but implies reliance on short-term funding. Revenue concentration in affluent consumers (43.7% from Global Consumer Services) exposes the company to shifts in spending patterns. Net margin of 14.23% is strong but could compress if credit losses rise from current low levels.
Market & Competitive Risks: The stock's trailing PE of 24.01x is a 9% premium to the industry average of 22.0x, making it vulnerable to valuation compression if growth disappoints. Beta of 1.045 implies market-like volatility, so a broad market downturn would likely hit AXP. Regulatory risks include potential caps on interchange fees (Durbin Amendment expansion) and increased scrutiny of card fees. Competition from Visa, Mastercard, and fintechs like PayPal could erode market share, though AXP's closed-loop network is a differentiator.
Worst-Case Scenario: A severe recession could cause consumer spending to contract and credit losses to spike, leading to earnings misses and multiple compression. The 52-week low of $288.34 represents a 19.6% downside from the current price of $358.44. If the stock were to retest that low, an investor could lose approximately 19.6%. The analyst low target of $319 implies an 11.0% downside, reflecting a less severe but still significant risk.
FAQ
The key risks are: (1) Macroeconomic downturn: A recession could reduce consumer spending and increase credit losses, pressuring earnings. With beta of 1.045, the stock is market-correlated. (2) Valuation risk: The trailing PE of 24.01x is near historical highs, leaving little room for error. Multiple compression could drive the stock down 11% to the analyst low target of $319. (3) Regulatory risk: Potential expansion of the Durbin Amendment or other interchange fee caps could reduce fee revenue. (4) Competitive risk: Visa, Mastercard, and fintechs like PayPal could erode market share, though AXP's closed-loop network is a differentiator. The most severe risk is a recession combined with rising credit losses, which could push the stock to the 52-week low of $288.34 (19.6% downside).
The 12-month forecast for AXP is moderately bullish. The base case (55% probability) expects the stock to trade between $350 and $400, with an average target of $374.94 (4.6% upside), assuming steady revenue growth of 8-10% and stable margins. The bull case (25% probability) targets $400-$450 (up to 25.5% upside), driven by stronger-than-expected spending and the Platinum fee hike. The bear case (20% probability) sees the stock falling to $288-$330 (down to 19.6% downside) if a recession or regulatory changes hit earnings. The most likely scenario is the base case, with the stock gradually appreciating as earnings grow into the valuation. Key assumptions include sustained consumer spending and no major regulatory shocks.
AXP's valuation is mixed: the trailing PE of 24.01x is a 9% premium to the industry average of 22.0x and near the high end of its 5-year range (11.3x-26.2x), suggesting it is slightly overvalued on past earnings. However, the forward PE of 17.77x is a 19% discount to the industry forward average of 22.0x, indicating the market expects significant earnings growth (35% EPS growth from $14.93 to $20.17). The PEG ratio of 2.46x suggests the stock is priced for above-average growth. Overall, AXP appears fairly valued on a forward basis but overvalued on trailing earnings, implying the market is pricing in optimistic expectations. If earnings materialize as expected, the current price is reasonable; if growth disappoints, the stock could see multiple compression.
American Express is a good buy for growth-oriented investors with a 12-month horizon. The stock offers a compelling risk/reward with accelerating revenue growth (10.28% YoY), expanding margins (net margin 14.23%), and strong free cash flow ($14.32B TTM). The forward PE of 17.77x is a 19% discount to the industry average, suggesting undervaluation relative to expected earnings. However, the trailing PE of 24.01x is near historical highs, and the stock is sensitive to macro conditions (beta 1.045). The biggest downside risk is a recession that could cut spending and increase credit losses, potentially driving the stock to the 52-week low of $288.34 (19.6% downside). For long-term investors, the company's brand moat and pricing power make it a solid hold, but short-term traders should be aware of the elevated valuation.
AXP is suitable for both long-term and short-term investment, but it is better aligned with a long-term horizon. The company's strong brand, pricing power, and consistent free cash flow ($14.32B TTM) support compounding returns over time. The dividend yield of 0.88% is modest but growing, and the payout ratio of 21% leaves room for increases. For short-term traders, the stock's beta of 1.045 and recent momentum (1-month +6.88%) offer opportunities, but the elevated trailing PE of 24.01x increases vulnerability to macro shocks. A minimum holding period of 12 months is recommended to allow earnings growth to justify the valuation. Long-term investors can benefit from the company's durable competitive advantages and capital return program.
